1. Medtech Insight
  2. >>Policy & Regulation

Cardio Catch-Up: Abbott Plans To Expand Pacemaker Market With Leadless Aveir DR

 
• By Reed Miller

The FDA approved Abbott’s Aveir DR dual-chamber leadless pacemaker system, which will complement Abbott’s Aveir VR technology and help Abbott compete directly with Medtronic in the growing leadless cardiac rhythm management device market.

Aveir
• Source: Abbott

The US Food and Drug Administration approvedAbbott’s Aveir dual chamber (DR) leadless pacemaker system.

About 80% of people who need a pacemaker to treat bradycardia or another abnormal heart rhythm will need dual-chamber...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Approvals

More from Policy & Regulation